{"id":745,"date":"2026-09-07T09:03:51","date_gmt":"2026-09-07T09:03:51","guid":{"rendered":"https:\/\/health.dzwonkinatelefon.net\/cipla-inks-partnership-with-chinas-qilu-pharma-for-cancer-biosimilar\/"},"modified":"2026-09-07T09:03:51","modified_gmt":"2026-09-07T09:03:51","slug":"cipla-inks-partnership-with-chinas-qilu-pharma-for-cancer-biosimilar","status":"publish","type":"post","link":"https:\/\/healthcare.hibisports.com\/?p=745","title":{"rendered":"Cipla inks partnership with China\u2019s Qilu Pharma for cancer biosimilar"},"content":{"rendered":"<div class=\"schemaDiv\" id=\"schemaDiv\">\n<p>Drugmaker Cipla, through subsidiary Invagen Pharmaceuticals, has entered into a partnership with China\u2019s Qilu Pharmaceutical for the exclusive licensing and supply of QL2107, a biosimilar to Keytruda (pembrolizumab) in the U.S.<\/p>\n<p>Qilu will be responsible for development, regulatory registration and supply of the product while Cipla USA Inc. will be responsible for the commercialisation of the asset by leveraging its strong commercial presence in the defined territory, the company said on Thursday (September 3).<\/p>\n<p>The partnership reflects Cipla\u2019s confidence in the long-term potential of biosimilars and supports its strategy to build a strong oncology-focused portfolio, said Achin Gupta, MD and and Global CEO of Cipla.<\/p>\n<p>\u201cWith our established commercial capabilities, we are well-positioned to successfully launch QL2107, subject to regulatory approval, and help ensure it reaches patients in need while lowering the cost of treatment,\u201d Cipla North America CEO Marc Falkin said.<\/p>\n<p>Qilu Pharmaceutical General Manager Hanchang Zhang said \u201cby combining our R&amp;D and manufacturing strengths with Cipla\u2019s U.S. commercial expertise, we aim to bring a high-quality, affordable pembrolizumab biosimilar to U.S. patients.\u201d<\/p>\n<div class=\"also-read print-hide\" data-ga-label=\"AlsoReadArticle\">\n<div class=\"element\">\n<div class=\"title\">\n\t\t\t\t\t\t\t\t\t\tFDA cancels drug sale licences of Cipla Pharma &amp; Life Sciences&#8217; Pune Carry and Forwarding unit<\/div>\n<div class=\"picture\"><img decoding=\"async\" src=\"https:\/\/th-i.thgim.com\/public\/incoming\/rs8c8j\/article71400793.ece\/alternates\/SQUARE_1200\/Cipla-to-buy-InGIMF46F7J.4.jpg.jpg\" data-src-template=\"https:\/\/th-i.thgim.com\/public\/incoming\/rs8c8j\/article71400793.ece\/alternates\/SQUARE_80\/Cipla-to-buy-InGIMF46F7J.4.jpg.jpg\" data-original=\"https:\/\/www.thehindu.com\/theme\/images\/th-online\/1x1_spacer.png\" alt=\"\" data-device-variant=\"SQUARE~SQUARE~SQUARE~SQUARE\" class=\"media-object lazy adaptive placeholder lazy\" width=\"100%\" height=\"100%\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The partnership reflects Cipla\u2019s confidence in the long-term potential of biosimilars and supports its strategy to build a strong oncology-focused portfolio.<\/p>\n","protected":false},"author":1,"featured_media":2327,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-745","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=\/wp\/v2\/posts\/745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=745"}],"version-history":[{"count":0,"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=\/wp\/v2\/posts\/745\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=\/wp\/v2\/media\/2327"}],"wp:attachment":[{"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/healthcare.hibisports.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}